Estrogenic Potency of Oral Replacement Therapy Estimated by the Induction of Pregnancy Zone Protein
- 11 January 1982
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 61 (1) , 75-79
- https://doi.org/10.3109/00016348209156956
Abstract
The induction of a highly estrogen-inducible plasma protein, the pregnancy zone protein/pregnancy associated α2-globulin (PZP/PAα2G), was used to design a sensitive method to quantify and ...This publication has 18 references indexed in Scilit:
- The Management of the Pre-Menopausal and the Post-Menopausal PatientPublished by S. Karger AG ,2015
- A COMPARISON OF SERUM OESTROGEN LEVELS AFTER PERCUTANEOUS AND ORAL ADMINISTRATION OF OESTRADIOL‐17βBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDSClinical Endocrinology, 1979
- Letter: Natural oestrogen replacement therapy and blood clotting.BMJ, 1976
- A radioimmunoassay for “the pregnancy zone protein”Clinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Effects of synthetic and natural estrogens on the coagulation system in post-menopausal womenPublished by Springer Nature ,1976
- The effects of ethinyl estradiol and conjugated equine estrogens on plasma lipids in oophorectomized womenPublished by Springer Nature ,1976
- Characterization of the “pregnancy zone protein” in relation to other α2-globulins of pregnancyBiochimica et Biophysica Acta (BBA) - Protein Structure, 1974
- A quantitative study of the pregnancy zone protein in the sera of pregnant and puerperal womenAmerican Journal of Obstetrics and Gynecology, 1974
- Evaluation of Equilin 3-Monosulfate and Other EstrogensArchives of internal medicine (1960), 1971